27 results
6-K
EX-99.1
GMAB
Genmab
29 Apr 24
TIVDAK® (tisotumab vedotin-tftv) Receives U.S. FDA Approval to Treat Recurrent or Metastatic Cervical Cancer
7:10pm
, Cervivor, Inc. “This full approval opens up new treatment paths for this patient community who have long faced limited options.”
About Cervical Cancer
6-K
EX-99.1
GMAB
Genmab
14 Feb 24
Genmab 2023 Annual Report
12:30pm
and community sustainability
Continue strong commitment to being a sustainable and responsible company
Further integrate environmental, social … , the campaign has grown into a grassroots effort that is actively building a community and sense of belonging among those impacted by the disease
6-K
EX-99.1
GMAB
Genmab
14 Feb 24
Genmab 2023 Annual Report
12:30pm
for patients ― Employee well-being and vitality ― Ethics and transparency ― Environmental and community sustainability ― Continue strong commitment to being … in the U.S. Today, the campaign has grown into a grassroots effort that is actively building a community and sense of belonging among those impacted
6-K
EX-99.1
GMAB
Genmab
25 Sep 23
Current report (foreign)
8:53am
d’Oncologia – L’Hospitalet, Barcelona, Spain. “This European Commission approval represents an important moment for the DLBCL patient community
6-K
EX-99.1
9no3yih543gcw hmeagx
21 Jul 23
Current report (foreign)
9:08am
6-K
EX-99.1
7n7bx72lz3oy8vgrrpy
19 May 23
Current report (foreign)
12:48pm
6-K
EX-99.1
wx3p2ao w68wgulbp9
16 Feb 22
Genmab 2021 Annual Report
11:29am
6-K
EX-99.1
4xqw 2kqkn7
16 Feb 22
Genmab 2021 Annual Report
11:29am
6-K
EX-99.1
3ex 523mf0fzxij4
23 Feb 21
Genmab 2020 Annual Report
12:38pm
6-K
EX-99.1
v8uunbkgtrj4wva6o
23 Feb 21
Genmab 2020 Annual Report
12:38pm
20-F
qy1hjn
30 Mar 20
Annual report (foreign)
5:12pm
6-K
EX-99.1
1t0gpk 6kv
19 Feb 20
Innovating antibodies, improving lives Annual Report 2019 Genmab A/S CVR No. 21 02 38 84
1:28pm
424B4
q7mjzxxx3
19 Jul 19
Prospectus supplement with pricing info
12:00am
F-1/A
6647bi6pe erzq
16 Jul 19
Registration statement (foreign) (amended)
8:05am
F-1/A
ux5qweexs65w2i
9 Jul 19
Registration statement (foreign) (amended)
6:13am
F-1
t4adzjppdfo834 wcyi
28 May 19
Registration statement (foreign)
4:27pm